{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:35:21Z","timestamp":1761932121832,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.rvsc.2004.02.002","type":"journal-article","created":{"date-parts":[[2004,3,30]],"date-time":"2004-03-30T05:20:36Z","timestamp":1080624036000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections"],"prefix":"10.1016","volume":"77","author":[{"given":"Jean-Pierre","family":"Gani\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"M\u00e9daille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Etor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2004.02.002_BIB1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/31.6.865","article-title":"Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa","volume":"31","author":"Asuquo","year":"1993","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1996.tb00001.x","article-title":"Fluoroquinolones in animal health","volume":"19","author":"Brown","year":"1996","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB3","first-page":"703","article-title":"Comparative kinetics of two orally administered fluoroquinolones in dogs: enrofloxacin versus marbofloxacin","volume":"147","author":"Cester","year":"1996","journal-title":"Revue de M\u00e9decine V\u00e9t\u00e9rinaire"},{"issue":"Suppl. 1","key":"10.1016\/j.rvsc.2004.02.002_BIB4","first-page":"155","article-title":"In vitro activity of enrofloxacin, marbofloxacin, orbifloxacin and ciprofloxacin against clinical strains of Staphylococcus intermedius isolated from dogs in Portugal","volume":"26","author":"Coelho-Baptista","year":"2003","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-3164.2000.00191.x","article-title":"Microbial flora and antimicrobial susceptibility patterns from dogs with otitis media","volume":"11","author":"Colombini","year":"2000","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB6","first-page":"695","article-title":"Antimicrobial therapy of skin and ear infections","volume":"37","author":"Dowling","year":"1996","journal-title":"Canadian Veterinary Journal"},{"issue":"Suppl. 6A","key":"10.1016\/j.rvsc.2004.02.002_BIB7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9343(91)90311-K","article-title":"Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones","volume":"91","author":"Dudley","year":"1991","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-3164.2001.00247.x","article-title":"Antimicrobial activity of enrofloxacin against Staphylococcus intermedius strains isolated from canine pyodermas","volume":"12","author":"Gani\u00e8re","year":"2001","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2885.2002.00381.x","article-title":"Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration","volume":"25","author":"Heinen","year":"2002","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00003088-199528020-00005","article-title":"The importance of pharmacokinetic\/pharmacodynamic surrogate marker to outcome","volume":"28","author":"Hyatt","year":"1995","journal-title":"Clinical Pharmacokinetic"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0007-1935(87)90002-9","article-title":"An overview of bacterial skin disease in the dog","volume":"143","author":"Ihrke","year":"1987","journal-title":"British Veterinary Journal"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-3164.1999.00179.x","article-title":"The use of fluoroquinolones in veterinary dermatology","volume":"10","author":"Ihrke","year":"1999","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB13","first-page":"402","article-title":"Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma","volume":"3","author":"Kay-Mugford","year":"2002","journal-title":"Veterinary Therapeutics"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-3164.1991.tb00127.x","article-title":"Carriage of Staphylococcus intermedius on the ventral abdomen of clinically normal dogs and those with pyoderma","volume":"2","author":"Lloyd","year":"1991","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-3164.1999.00187.x","article-title":"Fluoroquinolone resistance in Staphylococcus intermedius","volume":"10","author":"Lloyd","year":"1999","journal-title":"Veterinary Dermatology"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB16","first-page":"470","article-title":"Absorption, distribution and excretion of orbifloxacin in dogs and cats","volume":"50","author":"Matsumoto","year":"1997","journal-title":"Journal of the Japanese Veterinary Medical Association"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2460\/ajvr.1995.56.09.1219","article-title":"Pharmacokinetics of enrofloxacin in clinically normal dogs and mice and drug pharmacodynamics in neutropenic mice with Escherichia coli and staphylococcal infections","volume":"56","author":"Meinen","year":"1995","journal-title":"American Journal of Veterinary Research"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB18","unstructured":"National Committee for Clinical Laboratory Standards, 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards, fourth ed. NCCLS Document M7-A4, Villanova, PA"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB19","unstructured":"National Committee for Clinical Laboratory Standards, 2002. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard, second ed. NCCLS document M31-A2, Wayne, PA"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5326\/0380407","article-title":"Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992\u20131997)","volume":"38","author":"Petersen","year":"2002","journal-title":"Journal of the American Animal Hospital Association"},{"issue":"Suppl. 12M","key":"10.1016\/j.rvsc.2004.02.002_BIB21","first-page":"19","article-title":"Bactericidal and inhibitory activity of enrofloxacin and other fluoroquinolones in small animal pathogens","volume":"21","author":"Pirro","year":"1999","journal-title":"Compendium on Continuing Education for the Practicing Veterinarian"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB22","first-page":"107","article-title":"Antimicrobial drug use and resistance in dogs","volume":"43","author":"Prescott","year":"2002","journal-title":"Canadian Veterinary Journal"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2885.1995.tb00592.x","article-title":"Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates","volume":"18","author":"Spreng","year":"1995","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"10.1016\/j.rvsc.2004.02.002_BIB24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/46.5.669","article-title":"Application of fluoroquinolone pharmacodynamics","volume":"46","author":"Wright","year":"2000","journal-title":"Journal of Antimicrobial Chemotherapy"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528804000086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528804000086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T03:28:57Z","timestamp":1758511737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528804000086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0034528804000086"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2004.02.002","relation":{},"ISSN":["0034-5288"],"issn-type":[{"type":"print","value":"0034-5288"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2004.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}